STATE STREET CORP - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$8,000
-50.0%
22,7000.0%0.00%
Q2 2020$16,000
+128.6%
22,7000.0%0.00%
Q1 2020$7,000
-56.2%
22,7000.0%0.00%
Q4 2019$16,000
-27.3%
22,700
-30.2%
0.00%
Q3 2019$22,000
-58.5%
32,507
+2.0%
0.00%
Q2 2019$53,000
-65.6%
31,862
-48.4%
0.00%
Q1 2019$154,000
+2.0%
61,796
+4.0%
0.00%
Q4 2018$151,000
+31.3%
59,438
+161.8%
0.00%
Q3 2018$115,000
+55.4%
22,7000.0%0.00%
Q2 2018$74,000
-9.8%
22,7000.0%0.00%
Q1 2018$82,000
-76.2%
22,700
-54.4%
0.00%
Q1 2017$345,00049,8000.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 2,426,300$802,0000.74%
Cowen Prime Services LLC 1,411,500$466,0000.23%
GSA CAPITAL PARTNERS LLP 1,205,873$398,0000.07%
Nantahala Capital Management 5,113,958$1,690,0000.05%
HighMark Wealth Management LLC 80,000$26,0000.02%
Kalos Management, Inc. 72,858$24,0000.01%
Qube Research & Technologies Ltd 585,187$193,0000.00%
WINTON GROUP Ltd 190,146$63,0000.00%
Ironwood Financial, llc 1,571$1,0000.00%
Virtu Financial LLC 12,049$4,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders